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This cross-sectional survey aimed to examine the 
epidemiology of tuberculosis (TB) in European Union 
(EU) and European Economic Area (EEA) cities with 
populations greater than 500,000. National TB pro-
gramme managers were asked to provide data on big 
city population size, total number of notified TB cases 
in big cities and national notification rate for 2009. A 
rate ratio was calculated using the big city TB notifica-
tion rate as a numerator and country TB notification 
rate, excluding big city TB cases and population, as a 
denominator. Twenty of the 30 EU/EEA countries had at 
least one big city. Pooled rate ratios were 2.5, 1.0, and 
0.7 in low-, intermediate- and high-incidence countries 
respectively. In 15 big cities, all in low-incidence coun-
tries, rate ratios were twice the national notification 
rate. These data illustrate the TB epidemiology transi-
tion, a situation whereby TB disease concentrates in 
big cities as national incidence falls, most likely as a 
result of the higher concentration of risk groups found 
there. This situation requires targeted interventions 
and we recommend that big city TB data, including 
information about patients’ risk factors, are collected 
and analysed systematically, and that successful 
interventions are shared.
Introduction
Tuberculosis (TB) notification rates in the European 
Union (EU) have been declining at a mean annual rate 
of 4.4% since 2006, and in 2010 there were 73,996 
TB cases reported by the 27 EU Member States and 
the three European Economic Area (EEA) countries 
(Iceland, Liechtenstein and Norway) [1]. This resulted in 
notification rates below 100 per 100,000 population in 
all EU Member States for the first time in 2010. These 
national and EU-wide figures demonstrate the progress 
made towards the target of elimination, defined as less 
than one infectious (sputum smear-positive) case per 
1,000,000 population [2]. However, they hide some 
of the wide variations that exist between and within 
countries. 
Several publications have highlighted the higher notifi-
cation and incidence rates in EU/EEA big cities or met-
ropolitan areas, compared to non-urban areas, which 
is particularly evident among certain high-risk groups 
for TB overrepresented in big cities, including migrants 
from high-incidence countries, homeless people and 
drug and alcohol users [3–14]. The nomenclature used 
to describe major urban conurbations is variable within 
the literature, and includes big or large city, metro-
pole or metropolitan area, urban area. The definition 
is often based on population size or density criteria. 
Cities are administrative areas (municipalities), while 
metropolitan areas usually combine urban agglom-
eration with peripheral zones that are not necessarily 
urban in character, but are closely bound to the centre 
by employment or commerce [15]. Urban and suburban 
areas can also share the general big city social struc-
tures underpinning the congregation of urban high-risk 
groups. 
TB surveillance in Europe does not provide specific 
information on the epidemiology of TB in big cities, 
and data are only available routinely within coun-
tries and not readily accessible for international com-
parison. To inform the preparation of the consensus 
statement, which examined the structural determi-
nants of TB in EU/EEA big cities, as well as provided 
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recommendations for big city TB control [16], a survey 
of national TB programme managers was conducted. 
This cross-sectional survey aimed to provide detailed 
information of the epidemiology of TB in EU/EEA big 
cities, allowing an analysis of the case distribution and 
infection rates within low-, intermediate- and high-inci-
dence EU/EEA countries and their big cities.
Methods
Cross-sectional survey among national 
tuberculosis programme managers
For the purpose of this work we defined a big city as 
any municipality in the EU/EEA which had more than 
500,000 inhabitants in 2009.
World Health Organization (WHO) national TB pro-
gramme managers in EU/EEA countries were emailed 
by one of the authors (GdV) during the period from 
April 2011 to October 2012 using a list provided by 
the WHO Regional Office for Europe. TB programme 
managers received a form containing big city popula-
tion size data, the total number of national notified TB 
cases, and national notification rate for their country 
in 2009. These pre-populated data were taken from 
various sources. City population estimates were taken 
from the Eurostat Population and living conditions in 
Urban Audit cities (core city) [17] or where not avail-
able other Internet sources such as Wikipedia were 
used. Country population sizes were taken from the 
Tuberculosis Surveillance in Europe 2009 report [18]. 
The total number of national notified TB cases in 2009 
and the national notification rate were taken from the 
Tuberculosis Surveillance and monitoring in Europe 
2012 report [1]. National TB programme managers were 
asked to verify (or change as necessary) this pre-pop-
ulated data, or to send this information on to appropri-
ate public health officials responsible for TB control in 
the big city under consideration. They were also asked 
to provide the number of TB cases for each big city 
identified within their country in 2009. Data received 
back from the national TB programme managers, or 
public health authorities responsible for TB control in 
these big cities, were collated in an Excel spreadsheet. 
To examine the effect of big cities on TB incidence, we 
calculated rate ratios using the big city TB notification 
rate as a numerator and the country TB notification 
rate, excluding big city TB cases and population, as a 
denominator. National and big city TB notification rates 
and rate ratios were calculated in Stata (StataCorp LP, 
College Station, TX, USA) version 12.
Data were presented separately for low-, intermedi-
ate- and high-incidence EU/EEA countries and their 
big cities. Various definitions for low-incidence and 
high-incidence countries exist. The European Centre 
for Disease Prevention and Control (ECDC) defines 
countries with a TB incidence rate of <20 TB cases per 
100,000 population as low-incidence countries enter-
ing the phase of elimination [1]. For this study we 
classified countries into low-incidence countries (<20 
notifications per 100,000 population), mainly in west-
ern EU/EEA, and intermediate (20-50 notifications per 
100,000) and high-incidence countries (>50 notifica-
tions per 100,000), mainly in the central and eastern 
EU. 
Data from the tuberculosis control in European 
Union big cities working group
Annual notification rates for six selected big cities, 
available for the last 20 years, were collected in order 
to examine and exemplify time trends within these cit-
ies. Selection was based on participation in the work-
ing group, availability of data and its illustrative power 
to show a stable, declining or increasing trend. Two of 
these big cities with five-year inner city data available 
were selected to demonstrate the variation of TB notifi-
cation rates within their big cities. 
Results
Current epidemiology of tuberculosis in big 
cities – cross-sectional survey results
From the 30 EU/EEA countries, 20 had at least one big 
city (15/23 low-incidence, 3/5 intermediate and 2/2 
high-incidence countries), with 54 big cities in total, 
45 in low-incidence, seven in intermediate and two in 
high-incidence countries. All national TB programme 
managers or public health authorities from these big 
cities responded. 
The population in big cities represented 12.4% of the 
total EU/EEA population. The highest notification rates 
in big cities in low-incidence countries were observed 
in Birmingham and London, United Kingdom (58.0, 
44.4 respectively), followed by Brussels, Belgium 
(29.9), and Barcelona, Spain (27.0), all higher or con-
siderably higher compared to their national TB notifi-
cation rates (Table 1). The highest notification rates in 
big cities in intermediate and high-incidence countries 
were observed in Bucharest, Romania (87.1) and Riga, 
Latvia (43.0), followed by Sofia, Bulgaria (36.6) and 
Vilnius, Lithuania (31.9), all lower than their national 
TB notification rates. 
The highest rate ratios (big city notification rate more 
than twice the national notification rate) were found in 
15 big cities, all in low-incidence countries. Birmingham 
had the highest rate ratio followed by Brussels; 
London; and Rotterdam, the Netherlands (4.0, 3.2, 3.0 
and 3.0 respectively); Copenhagen, Denmark; Milan, 
Italy; Oslo, Norway; Paris, France; and Turin, Italy (all 
2.8); Amsterdam, the Netherlands (2.7); Rome, Italy 
(2.5),; Frankfurt, Germany (2.4); Cologne, Germany 
(2.3); Athens, Greece (2.2); and Genoa, Italy (2.0). 
Table 2 shows the aggregated population size, TB 
caseload and notification rates in EU/EEA countries 
and big cities according to notification rate at country 
level. In 2009, the TB notification rate across the EU/
EEA was 15.8 per 100,000 inhabitants and 22.3 in big 
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Table 1
Population size, tuberculosis cases and notification rates in low-, intermediate- and high-incidence European Union/European 
Economic Area countries and their big cities (>500,000 population), and rate ratio for big cities, 2009 (20 countries, 54 cities)




Low-incidence countries (TB incidence <20 per 100,000 population)
Austria 8,355,260 698 8.4 Vienna 1,698,957 256 15.1 1.8
Belgium 10,666,866 994 9.3 Brussels 1,068,532 320 29.9 3.2
Czech Republic 10,467,542 695 6.6 Prague 1,233,211 128 10.4 1.6
Denmark 5,511,451 337 6.1 Copenhagen 667,228 113 16.9 2.8
Finland 5,326,314 417 7.8 Helsinki 583,350 58 9.9 1.3
France 62,131,000b 5,114b 8.2 Paris 2,199,500 515 23.4 2.8Marseille 852,396 103 12.1 1.5
Germany 82,002,356 4,419 5.4
Berlin 3,442,675 269 7.8 1.4
Hamburg 1,774,224 178 10.0 1.9
Munich 1,330,440 103 7.7 1.4
Hannover 1,130,262c 70 6.2 1.1
Cologne 998,105 126 12.6 2.3
Frankfurt 671,927 87 12.9 2.4
Bremen 661,716 57 8.6 1.6
Stuttgart 601,646 49 8.1 1.5
Dusseldorf 586,217 57 9.7 1.8
Dortmund 581,308 47 8.1 1.5
Essen 572,569 21 3.7 0.7
Dresden 518,862 30 5.8 1.1
Leipzig 517,052 44 8.5 1.6
Nuremberg 503,673 44 8.7 1.6
Greece 11,260,402 594 5.3 Athens 745,514 91 11.5 2.2
Hungary 10,030,975 1,407 14.0 Budapest 1,695,000 321 18.9 1.4
Italy 60,045,068 4,244 7.1
Rome 2,724,347 487 17.9 2.5
Milan 1,650,000c 327 19.8 2.8
Naples 963,661 68 7.1 1.0
Turin 909,538 183 20.1 2.8
Palermo 659,433 51 7.7 1.1
Genoa 611,171 87 14.2 2.0
Netherlands 16,485,787 1,157 7.0 Amsterdam 755,605 143 18.9 2.7Rotterdam 699,609 128 21.3 3.0
Norway 4,799,252 358 7.5 Oslo 575,475 121 21,0 2.8
Spain 45,828,172 7,592 16.6
Madrid 3,255,944 580 17.8 1.1
Barcelona 1,455,000 393 27.0 1.6
Valencia 814,208 177 21.7 1.3
Seville 703,206 107 15.2 0.9
Zaragoza 674,317 117 17.4 1.0
Malaga 568,305 93 16.4 1.0
Sweden 9,256,347 617 6.7 Stockholm 810,120 39 4.8 0.7Gothenburg 500,197 49 9.8 1.5
United Kingdom 61,179,256 8,917 14.6
London 7,753,555 3,440 44.4 3.0
Glasgow 878,135 213 24.3 1.7
Birmingham 687,700 399 58.0 4.0
Leeds 787,700 124 15.7 1.1
Sheffield 547,000 80 14.6 1.0
Intermediate-incidence countries (TB incidence 20–50 per 100,000 population)
Bulgaria 7,606,551 2,910 38.3 Sofia 1,249,798 457 36.6 1.0
Latvia 2,261,294 978 43.2 Riga 709,145 305 43.0 1.0
Poland 38,135,876 8,236 21.6
Warsaw 1,711,466 304 17.8 0.8
Krakow 754,853 73 9.7 0.4
Lodz 744,541 187 25.1 1.2
Wroclaw 632,240 175 27.7 1.3
Poznan 556,022 70 12.6 0.6
High-incidence countries (TB incidence >50 per 100,000 population)
Lithuania 3,349,872 2,081 62.1 Vilnius 558,165 178 31.9 0.5
Romania 21,498,616 23,164 107.7 Bucharest 1,944,226 1,694 87.1 0.8
TB: :tuberculosis.
a Rate ratio calculated using the big city TB notification rate as a numerator and country TB notification rate, excluding big city TB cases and 
population, as a denominator.
b Excluding overseas districts of France.
c Populations of Hannover and Milan are for the greater municipal area/conglomerate. 
Cities shown in blue are those with a rate ratio greater than or equal to 2.0.
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cities, resulting in a rate ratio of 1.5. Pooled rate ratios 
were 2.5, 1.0, and 0.7 in low-, intermediate- and high-
incidence countries respectively. Big cities of EU/EEA 
low-incidence countries accounted for 27.0% (10,493 of 
38,868) of the notified TB cases while only 12.8% of 
the general population lived in these cities. 
Tuberculosis control in big cities case studies
Figure 1 presents examples of trends in TB notification 
rates over the past two decades in selected EU big cit-
ies. In the past two decades Barcelona and Paris noti-
fication rate has reduced from almost 70 per 100,000 
population to around 25 while London has experienced 
almost a doubling of notification rates since 1990 from 
around 24 per 100,000 population to 45. Brussels con-
tinues to have high notification rates between 30 and 
40 per 100,000 population, while Berlin, Germany, 
maintains a low notification rate of around 10, although 
an increase was observed in the past two years. In 
Rotterdam, the TB notification rate initially almost dou-
bled from 1990 and reached 29 per 100,000 in 2003 
but then the increasing trend reversed to a rate of 15 
per 100,000 in 2011.
Notification rates also vary within different districts of 
a city. In London and in Rotterdam, levels were high-
est in the inner city districts (Figure 2). However, this 
is not consistent across all EU big cities; for example 
in Stockholm, Sweden, socially disadvantaged groups 
tend to live outside the city, in suburbs with higher 
notification rates than for the city itself (personal com-
munication, J Jonsson, December 2011).
Discussion
This study presents the results of a cross-sectional 
survey of national and big city TB programme manag-
ers, examining the distribution of TB cases and rates 
within EU/EEA countries and big cities. In 2009, 15 
out of 54 EU/EEA big cities had a notification rate two 
times greater than the national notification rate and 
all were in low-incidence countries. The TB notification 
rate across the EU/EEA was 15.8 per 100,000 popula-
tion (excluding overseas districts of France) compared 
to 22.3 in the big cities. In low-incidence EU/EEA coun-
tries, 27.0% of TB cases lived in big cities, compared 
to only 12.8% of the general population residing there. 
These data illustrate the high levels of TB found in 
EU/EEA big cities that are not obvious when examin-
ing national data alone. Analysis of available long-
term data for EU/EEA big cities show that while there 
is a general downward trend, some big cities such as 
London have seen an increase in notifications over 
recent years.
In the United States (US) a study examined all incident 
cases of TB reported to the Centers for Disease Control 
and Prevention’s National Tuberculosis Surveillance 
System (NTSS) from 2000 to 2007 [19]. This study 
found that a significant TB burden occurs in large US 
cities with 36% of all US TB patients living in 48 cities 
compared with only 15% of the general US population. 
TB incidence rates in these cities (12.1/100,000) were 










Population TB cases Notification ratea [range]
Number of 




(0–20 cases) 23 417,299,635 38,868
9.3






(20–50 cases) 5 59,971,386 15,406
25.7






(>50 cases) 2 24,848,488 25,245
101.6










CI: confidence interval; EU: European Union; EEA: European Economic Area; TB: tuberculosis
Low-incidence countries are defined as having <20 notifications per 100,000 population; intermediate-incidence countries as having 20–50 
notifications per 100,000 population; and and high-incidence countries countries as having >50 notifications per 100,000 population.
a Cases per 100,000 population per year.
b A rate ratio was calculated using the big city TB notification rate as a numerator and country TB notification rate as a denominator, after the 
exclusion of big cities population and TB cases from this national figure. 
c Excluding overseas districts of France.
Table 2
Aggregated population size, number of notified tuberculosis cases and notification rates stratified by tuberculosis 
notification rate and rate ratios of big city and country incidences, European Union/European Economic Area countries 
and their big cities, 2009 (30 countries, 45 cities)
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A European study conducted in 1999–2000 contacted 
national TB coordinators in western European countries 
(or their public health counterparts in the appropriate 
cities) and asked them to provide TB epidemiologi-
cal data [5]. Notification rates in cities were found to 
range from less than 10 per 100,000 population to 70. 
Notification rates were more than double the overall 
rate for the country in eight of the cities (Brussels; 
Copenhagen; Paris; Thessaloniki, Greece; Milan; 
Amsterdam; The Hague, the Netherlands; and London). 
These findings were consistent with those of our study 
which also found Brussels, Copenhagen, Paris, Milan, 
Amsterdam, and London to have a rate ratio of greater 
than two (Thessaloniki and The Hague did not meet our 
criteria for big city). In addition to the disparities that 
exist between levels within countries and their big cit-
ies, there is also variation within big cities themselves 
within different districts of a city.
Our study used a narrow definition of TB in big cities 
to refer to cases residing within the administrative 
boundaries of a municipality, although for two big cit-
ies (Hannover, Germany; and Milan) information was 
not available. TB case ascertainment is a dynamic pro-
cess both in EU/EEA countries and in their big cities, 
so the actual number of cases and notification rate 
may change over time. Since we collected the data on 
TB in big cities at approximately the same time as EU/
EEA countries uploaded the revised 2009 data to ECDC, 
presented in the 2012 report [1], we optimised compari-
son of data. Our study did not collect data on risk fac-
tors of urban and national TB cases, which may further 
explain the urban-rural difference found in this study. 
We also did not gather information on TB control strat-
egies and resources, which may differ in urban and 
rural areas, and effect case detection and notification 
levels.
Factors contributing to the high notification rates in 
western EU/EEA big cities are likely to be related to the 
relatively high proportion of immigrants from high-inci-
dence countries, outbreaks among homeless people, 
drug users and alcoholics, and on-going transmission 
to other urban populations [5,10,19,20]. Factors such 
as the high population density in big cities, the high 
prevalence of congregate settings, population pockets 
in big cities with lower socio-economic status [21], and 
at times inadequate public health responses [22–24], 
are also likely to contribute to higher TB notification 
rates in big cities.  
Our study shows that with TB notification rates declin-
ing to less than 20 per 100,000 population, in most EU/
EEA countries, TB rates in big cities remain higher than 
the national notification rate. Our data also illustrate 
the TB epidemiology transition: a situation whereby TB 
Figure 1










































Selection was based on participation in the European Union big cities working group, availability of data and its illustrative power to show a 
stable, declining or increasing trend. Paris data available from 1993, Berlin data available from 2001.
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Figure 2
































































disease concentrates in big cities as national incidence 
falls, most likely as a result of the risk groups found 
there. We expect that countries going down from high 
and intermediate incidence to low-incidence are likely 
to experience the same phenomenon and should con-
sider this changing epidemiological situation in their 
TB control programmes in a timely manner. To tackle 
this problem we recommend that big city TB data, 
including risk profiles of patients, are collected and 
analysed systematically and that interventions to con-
trol TB successfully in big cities are shared. The accom-
panying consensus statement on TB goes some way to 
ensuring consistency in approaches that are required 
[16].
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